Process for obtaining low molecular weight heparins endowed with elevated pharmacological properties, and product so obtained
Heparin fragments having selective anticoagulation activity
Novel heparin derivative, method for production thereof, and method for rendering biomedical materials antithrombotic by use of the novel heparin derivative
Heparinase derived anticoagulants
Oligosaccharides having anti-Xa activity and pharmaceutical compositions containing them
Process for making oligosaccharides having anti-Xa activity and the resulting oligosaccharides
Anti-thromboticum based on polysacharides, method for its preparation and pharmaceutical compositions
AbstractAcetyl ester derivatives of heparin are disclosed. These derivatives exhibit improved Anti-Xa activity in relation to their global anticlotting activity.